Clinical Impact of Nosocomial Klebsiella Bacteremia in Critically Ill Patients
| Autor: | Francis Colardyn, K Vandewoude, Stijn Blot |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty Critical Illness Bacteremia Severity of Illness Index law.invention Cohort Studies law Internal medicine Severity of illness medicine Humans Intensive care medicine Survival rate Aged Retrospective Studies Cross Infection APACHE II business.industry Mortality rate Retrospective cohort study General Medicine Middle Aged medicine.disease Intensive care unit Klebsiella Infections Survival Rate Intensive Care Units Infectious Diseases Case-Control Studies Female business Cohort study |
| Zdroj: | European Journal of Clinical Microbiology & Infectious Diseases. 21:471-473 |
| ISSN: | 1435-4373 0934-9723 |
| DOI: | 10.1007/s10096-002-0746-9 |
| Popis: | In order to determine the clinical impact of Klebsiella bacteremia on critically ill patients, a matched cohort study was conducted between January 1992 and December 2000. During the study period, all intensive care unit (ICU) patients with nosocomial Klebsiella bacteremia were defined as cases (n=52), but two of these patients were excluded from the matched cohort due to incomplete medical records. The remaining 50 patients were matched at a ratio of 1:2 with control patients (n=100) on the basis of the APACHE II severity of disease classification system. Patients with Klebsiella bacteremia experienced acute renal failure and hemodynamic instability more often than controls. They also had a longer ICU stay and longer ventilator dependence. In-hospital mortality rates for cases and controls were nearly equal (36% vs. 37%, respectively; P=0.905). In conclusion, after adjusting accurately for severity of underlying disease and acute illness, no difference in mortality was found between ICU patients with Klebsiella bacteremia and their matched control subjects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink